1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015

Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015" provides data on the Follicular Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Follicular Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Follicular Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Follicular Thyroid Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Follicular Thyroid Cancer 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Follicular Thyroid Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Bayer AG 31
Clinical Trial Overview of Bayer AG 31
Eisai Co., Ltd. 32
Clinical Trial Overview of Eisai Co., Ltd. 32
Exelixis, Inc. 33
Clinical Trial Overview of Exelixis, Inc. 33
AstraZeneca PLC 34
Clinical Trial Overview of AstraZeneca PLC 34
Clinical Trial Overview of Top Institutes / Government 35
National Cancer Institute 35
Clinical Trial Overview of National Cancer Institute 35
University of Washington 37
Clinical Trial Overview of University of Washington 37
University of Kentucky 38
Clinical Trial Overview of University of Kentucky 38
University of California, San Francisco 39
Clinical Trial Overview of University of California, San Francisco 39
MedStar Washington Hospital Center 40
Clinical Trial Overview of MedStar Washington Hospital Center 40
Mashhad University of Medical Sciences 41
Clinical Trial Overview of Mashhad University of Medical Sciences 41
Memorial Sloan Kettering Cancer Center 42
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 42
University of Colorado 43
Clinical Trial Overview of University of Colorado 43
The National Institute of Diabetes and Digestive and Kidney Diseases 44
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 44
University of Michigan 45
Clinical Trial Overview of University of Michigan 45
Five Key Clinical Profiles 46
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 84

List of Tables
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Follicular Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Follicular Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Follicular Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Follicular Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Follicular Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Follicular Thyroid Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Follicular Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 31
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 32
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2015* 33
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 34
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 35
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 37
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2015* 38
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 39
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MedStar Washington Hospital Center, 2015* 40
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2015* 41
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 42
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015* 43
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 44
Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2015* 45

List of Figures
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Follicular Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Follicular Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Follicular Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Follicular Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Follicular Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Follicular Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 82

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.